Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee-Reference-Cited by-同舟云学术

Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee

Published:2023-04 Issue:3 Volume:14 Page:101406
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Neuendorff Nina Rosa,Gagelmann Nico,Singhal Surbhi,Meckstroth Shelby,Thibaud Vincent,Zhao Yue,Mir Nabiel,Shih Yung-Yu,Amaro Danielle M.C.,Roy Mukul,Lombardo Joseph,Gjærde Lars Klingen,Loh Kah Poh

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference139 articles.

1. Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives;Mikkael;Haematologica,2008

2. Survival for older patients with acute myeloid leukemia: a population-based study;Oran;Haematologica,2012

3. Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States;Zeidan;Blood Adv,2020

4. Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries;Récher;Leukemia,2021

5. Clinical outcome of older adults with acute myeloid leukemia: an analysis of a large tertiary referral center over two decades;Ihlow;J Geriatr Oncol,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial;Blood;2024-08-01

2. The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches;Biochemical Society Transactions;2023-08-01